In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes
Open Access
- 12 November 2013
- journal article
- research article
- Published by Wiley in Microbiology and Immunology
- Vol. 58 (1), 1-8
- https://doi.org/10.1111/1348-0421.12109
Abstract
To investigate the antifungal drug susceptibility of fungi responsible for dermatomycoses, minimum inhibition concentration (MIC) tests were performed in 44 strains of dermatophytes, including Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton tonsurans, Microsporum canis, Microsporum gypseum and Epidermophyton floccosum, with six antifungal drugs (amorolfine, terbinafine, butenafine, ketoconazole, itraconazole and bifonazole) by broth microdilution assay according to Clinical Laboratory Standard Institute protocols. Six possible dermatomycosis‐causing non‐dermatophytic fungi were also tested. The two major causes of tinea, T. rubrum and T. mentagrophytes, showed significantly different sensitivities to ketoconazole and bifonazole. Clinically derived dermatophytes were sensitive to the six antifungal drugs tested. However, non‐dermatophytes, especially Fusarium spp., tended to be resistant to these antifungal drugs. In Trichophyton spp., the MICs of non‐azole drugs had narrower distributions than those of azoles. To evaluate the effects of antifungal drug combinations, the fractional inhibitory concentration index was calculated for the combination of amorolfine and itraconazole as representative external and internal drugs for dermatophytes. It was found that this combination had synergistic or additive effects on most dermatophytes, and had no antagonistic effects. The variation in susceptibility of clinically derived fungal isolates indicates that identification of causative fungi is indispensable for appropriately choosing effective antifungal drugs in the early stages of infection. The results of combination assay suggest that multiple drugs with different antifungal mechanisms against growth of dermatophytes should be used to treat refractory dermatomycoses, especially onychomycosis.Keywords
This publication has 33 references indexed in Scilit:
- Efficacious Treatment of Non-Dermatophyte Mould Onychomycosis with Topical Amphotericin BDermatology, 2011
- Mechanism of the Synergistic Effect of Amiodarone and Fluconazole in Candida albicansAntimicrobial Agents and Chemotherapy, 2010
- Comparison between the Standardized Clinical and Laboratory Standards Institute M38-A2 Method and a 2,3-Bis(2-Methoxy-4-Nitro-5-[(Sulphenylamino)Carbonyl]-2 H -Tetrazolium Hydroxide- Based Method for Testing Antifungal Susceptibility of DermatophytesJournal of Clinical Microbiology, 2008
- Comparison of the Sensititre YeastOne® Colorimetric Antifungal Panel with the Modified Clinical and Laboratory Standards Institute Broth Microdilution (M38-A) Method for Antifungal Susceptibility Testing of DermatophytesChemotherapy, 2008
- Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in SpainBritish Journal of Dermatology, 2008
- Synergistic Effect of Posaconazole and Caspofungin against Clinical ZygomycetesAntimicrobial Agents and Chemotherapy, 2007
- Investigation of conditions involved in the susceptibility of the dermatophyte Trichophyton rubrum to photodynamic treatmentJournal of Antimicrobial Chemotherapy, 2007
- Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A)Journal of Medical Microbiology, 2007
- In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activityBritish Journal of Dermatology, 2003
- Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in SpainBritish Journal of Dermatology, 2001